Comparison of Different Methods to Test MGMT Status in Glioblastoma Patients
P2/3 Randomized Study of Toca 511 & Toca FC Versus SOC in Subjects Undergoing Surgery for Recurrent GBM/AA
Proton Chemoradiotherapy for High-Risk Soft Tissue Sarcomas
Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
† Study has passed its completion date and status has not been verified in more than two years.